NEW YORK, March 8, 2017 /PRNewswire/ -- Dozens of talcum powder lawsuits filed on behalf of women who allegedly developed ovarian cancer due to Johnson & Johnson's talc-based powders are moving forward in a multidistrict litigation now underway in the U.S. District Court, District of New Jersey. According to a letter submitted to the Court on March 3rd, the parties have been meeting and conferring via telephone on a weekly basis, and have already agreed on a Protective Order. The Order was submitted to and entered by the Court on March 1st. The letter also indicated that discussions regarding an ESI protocol, Preservation Order and alternative options to a Plaintiff Fact Sheet are ongoing. (In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation – MDL No.2738)
"Women who are concerned that the long-term use of talcum powder for feminine hygiene purposes contributed to their ovarian cancer continue to contact our Firm, as do the surviving loved ones of those who succumbed to the disease. We are pleased that the federal talcum powder litigation is moving forward, and will continue to monitor the proceeding for any developments that may impact our clients' cases," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to victims of ovarian cancer allegedly related to the use of Johnson & Johnson's talc-based powders.
Talcum Powder Litigation
Johnson & Johnson reported in a recent filing with the U.S. Securities & Exchange Commission (SEC) that it has been named a defendant in at least 3,100 product liability claims involving its talc-based powders and ovarian cancer. As of February 15th, 134 cases were pending in the multidistrict litigation underway in the District of New Jersey.
Plaintiffs pursuing talcum powder lawsuits against Johnson & Johnson claim that the regular and repeated genital application of Baby Powder and Shower-to-Shower talc-based powders contributes to the development of ovarian cancer. They accuse the company of intentionally ignoring research dating back to the 1970s that suggests such a link, and assert that Johnson & Johnson's alleged failure to warn consumers of this risk was driven by a desire to protect revenues derived from the sale of its talcum powder products.
One of the nation's largest talcum powder litigations is underway in Missouri's 22nd Circuit Court in St. Louis, where four cases have already gone to trial. Only one jury has found in favor of Johnson & Johnson. Plaintiffs in three other trials were awarded compensatory and punitive damages amounting to $72 million, $70 million and $55 million. Missouri's fifth talcum powder trial is scheduled to begin in April. (Case No 1422-CC09012-01)
Women who were diagnosed with ovarian cancer following the long-term use of talc-based products for feminine hygiene purposes may be eligible to file their own talcum powder lawsuit. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
SOURCE Bernstein Liebhard LLP